These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6443085)

  • 21. The ratio of factor VIII-related antigen and factor VIII biological activity as an index of hypercoagulability and intravascular clotting.
    Denson KW
    Thromb Res; 1977 Jan; 10(1):107-19. PubMed ID: 300511
    [No Abstract]   [Full Text] [Related]  

  • 22. Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study.
    Lee JH; Lee KH; Kim S; Lee JS; Kim WK; Park CJ; Chi HS; Kim SH
    Bone Marrow Transplant; 1998 Nov; 22(9):883-8. PubMed ID: 9827816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of thrombelastography with common coagulation tests in preeclamptic and healthy parturients.
    Wong CA; Liu S; Glassenberg R
    Reg Anesth; 1995; 20(6):521-7. PubMed ID: 8608071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined factor VIII and IX inhibitors in a girl.
    Reussi C; Altman R; Rouvier J; Maino R
    Thromb Diath Haemorrh; 1966 Dec; 16(3):549-58. PubMed ID: 5996674
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies on molecular size distribution of factor VIII-related antigen in patients with Von Willebrand's disease and their parents].
    Mikami S; Nishino M; Yasui M; Okubo Y; Shima H; Fukui H
    Rinsho Ketsueki; 1982 Aug; 23(8):1198-204. PubMed ID: 6815349
    [No Abstract]   [Full Text] [Related]  

  • 26. [Observations on hematologic parameters in thromboangiitis obliterans of the blood stasis syndrome].
    Zheng P
    Zhong Xi Yi Jie He Za Zhi; 1986 Jun; 6(6):332-5, 323. PubMed ID: 2430727
    [No Abstract]   [Full Text] [Related]  

  • 27. Selected hemostatic abnormalities associated with neoplastic disease.
    Ito R; Statland BE
    Clin Lab Med; 1982 Sep; 2(3):599-625. PubMed ID: 6814812
    [No Abstract]   [Full Text] [Related]  

  • 28. Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease.
    Lubetsky A; Schulman S; Varon D; Martinowitz U; Kenet G; Gitel S; Inbal A
    Thromb Haemost; 1999 Feb; 81(2):229-33. PubMed ID: 10063997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of desmopressin acetate (DDAVP) as a test of the fibrinolytic capacity of patients--analysis of responders and non-responders.
    Brommer EJ; Barrett-Bergshoeff MM; Allen RA; Schicht I; Bertina RM; Schalekamp MA
    Thromb Haemost; 1982 Oct; 48(2):156-61. PubMed ID: 6817444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antithrombin III in normal pregnancy and late toxicoses].
    Kholevich B; Kamenov V
    Akush Ginekol (Sofiia); 1984; 23(4):306-9. PubMed ID: 6486368
    [No Abstract]   [Full Text] [Related]  

  • 32. Heparin cofactor activity and antithrombin III antigen levels in preeclampsia.
    Friedman KD; Borok Z; Owen J
    Thromb Res; 1986 Aug; 43(4):409-16. PubMed ID: 3764801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of preeclampsia and eclampsia on cord blood coagulation tests.
    Djelmis J; Buković D; Ivanisević M; Kovacević V; Pfeifer D
    Coll Antropol; 1998 Jun; 22(1):113-7. PubMed ID: 10097426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Application if different techniques to the diagnosis of von Willebrand's disease (author's transl)].
    Solana JM; Rocha E; Arrizabalaga B; López A; Febres R; Fernández J
    Sangre (Barc); 1981; 26(6):1156-63. PubMed ID: 6805084
    [No Abstract]   [Full Text] [Related]  

  • 35. The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor.
    Eikenboom JC; Castaman G; Kamphuisen PW; Rosendaal FR; Bertina RM
    Thromb Haemost; 2002 Feb; 87(2):252-7. PubMed ID: 11859851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology of the clinical manifestations of preeclampsia.
    Hladunewich M; Karumanchi SA; Lafayette R
    Clin J Am Soc Nephrol; 2007 May; 2(3):543-9. PubMed ID: 17699462
    [No Abstract]   [Full Text] [Related]  

  • 37. [Preliminary report of plasma antithrombin III in pregnant women].
    Ding ML
    Zhonghua Fu Chan Ke Za Zhi; 1987 May; 22(3):157-8, 190. PubMed ID: 3652811
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pregnancy toxemia and blood coagulation].
    Elrad V
    Harefuah; 1972 Nov; 83(9):391-2. PubMed ID: 4669747
    [No Abstract]   [Full Text] [Related]  

  • 39. Factor VIII related antigen: an improved enzyme immunoassay.
    Short PE; Williams CE; Picken AM; Hill FG
    Med Lab Sci; 1982 Oct; 39(4):351-5. PubMed ID: 6817017
    [No Abstract]   [Full Text] [Related]  

  • 40. The analysis of factor VIII.
    Giddings JC
    Med Lab Sci; 1982 Oct; 39(4):339-43. PubMed ID: 6817015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.